logo

CHINA MED(NSDQ:CMED)
China Medical Technologies, Inc. is a China-based medical device company that develops, manufactures and markets products using HIFU for the treatment of solid cancers and benign tumors in China. They design and development HIFU tumor therapy devices in China. Their HIFU therapy system is SFDA-approved and has been used to treat over 20,000 patient cases. In addition, they offer an integrated luminescence immunoassay IVD system using ECLIA technology to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood or urine.
# Employees: 708
Address: No 24 Yong Chang North Road Beijing Economic-Technological Development Area,Beijing,,CHN
Phone: 86 10 6787 1166
Fax: 86 10 6788 9588
Website: www.chinameditech.com
Email: ir@chinameditech.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Xiaodong Wu (Chmn.; C.E.O.)
Takyung Sam Tsang (C.F.O.; Dir.)
Feng Charles Zhu (V.P.)
Zhong Chen (Chief technology off.)
Yuedong Li (Dir.,)
Dividend
Ex-Dividend Date: 9/28/2009
Annual Dividend: $0.53
Current Dividend Yield: $4.21
Dividend Paid (3 months): $0.53
Indicated Dividend: $0.34
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 3/8/2010
Mean EPS (Next Qtr): ($0.01)
Mean EPS (Year): $1.52
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): 8.280
Number of Estimates: 1
Shares Performance
Period CMED Compare to S&P
YTD -37.91 % -48.61 %
4 Weeks -25.69 % -26.50 %
12 Weeks -18.89 % -23.53 %
Shares Information
Analyst Coverage: Y
Avg Volume: 614928
Shares Outstanding: 27M
Market Cap: $0.34B
52 Week High: $25.01
52 Week Low: $11.82
P/E Ratio: 7.960
PEG Ratio: -0.010
Split: On 1/1/1990 CMED split by factor of 0.100
Earnings Performance
EPS Growth in Last Quarter: -82.35 %
EPS Growth in Last Year: -90.16 %
Sales Growth in Last Quarter: -20.48 %
Sales Growth in Last Quarter: -43.13 %
Financials
Qtr Book Value: $1.30
Cash Flow/Share: $4.43
Change in Payout Ratio: -0.010
Price/Sales: 2.770
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia